modelParacetamol_Langeskov2022_reference
Extends from Pharmacolibrary.Pharmacokinetic.Models.PK_2C_enteral.
Information
| name: | paracetamol |
| ATC code: | N02BE01 |
| model: | two compartments, oral dosing (PK_2C_enteral) |
| source: | Langeskov EK et al. 2022 |
| population: | healthy obese adults |
| measured compound: | paracetamol |
| review: | accepted with caveats |
| record page: | pharmacolibrary-docs |
Parameters as reported in the paper
| parameter | value | unit | meaning |
|---|---|---|---|
| ka (h−1) (Placebo) | 5.72 | h−1 | kabs |
| V1/F (L) | 48.5 | L | V1/F |
| Cl/F (L/h) | 25.9 | L/h | CL/F |
| V2/F (L) | 55.4 | L | V2/F |
| Cl2/F (L/h) | 199 | L/h | Q/F |
| Tlag (h) | 0.16 | h | tlag |
| ktr (h−1) (Placebo) | 7.28 | h−1 | ktr |
| Cl2/F (L/h) a | 873 | L/h | Q2/F |
| Θkacovariate | 0.829 | equation variable | |
| Θktrcovariate | 0.791 | equation variable |
About paracetamol
Paracetamol is a pain-relieving and fever-lowering medicine used to treat pain, fever, and related conditions such as colds and flu. It is very widely used worldwide, appears on the WHO essential medicines list, and is available over the counter in the UK and approved by the FDA.
Summary written by glm-5.3-flash from Wikidata Q57055 and the WHO ATC classification; not checked by a person.
Identity, molar mass and metabolites: Paracetamol.
References
Langeskov EK et al. (2022). Population pharmacokinetic of paracetamol and atorvastatin with co-administration of semaglutide. Pharmacology research & perspectives 10(4):e00962. DOI:10.1002/prp2.962 PUBMED:35799471
Parameters
| Type | Name | Default | Description |
|---|---|---|---|
| Real | Cl_ref | 7.194444444444444e-06 | Cl [m3/s] |
| Real | Vd_ref | 0.0485 | Vd [m3] |
| Modelica.Units.SI.Mass | weight (from PK_1C) | 75 | patient weight (kg) |
| Modelica.Units.SI.SpecificVolume | VdPerKg (from PK_1C) | 0.0009 | Volume of distribution per kg (default 0.9 L/kg) |
| Modelica.Units.SI.MassFraction | F (from PK_1C) | 1 | bioavailability (0-1) |
| Pharmacolibrary.Types.Clearance | Cl (from PK_1C) | 2.7777777777777776e-7 | clearance |
| Modelica.Units.SI.Time | adminTime (from PK_1C) | 60 | first administration time (s) |
| Modelica.Units.SI.Time | adminDuration (from PK_1C) | 600 | administration duration (s) |
| Modelica.Units.SI.Time | adminPeriod (from PK_1C) | 8*60*60 | period of administration (default 8 hours)(s) |
| Pharmacolibrary.Types.Mass | adminMass (from PK_1C) | 1e-4 | administration mass (mg) |
| Integer | adminCount (from PK_1C) | 8 | number of dose administered (1) |
| Pharmacolibrary.Types.Volume | Vd (from PK_1C) | VdPerKg*weight | Volume of distribution (m3) |
| Pharmacolibrary.Types.Volume | Vdp (from PK_2C) | VdpPerKg*weight | Volume of distribution (m3) |
| Modelica.Units.SI.SpecificVolume | VdpPerKg (from PK_2C) | 0.0009 | Volume of distribution peripheral per kg (default 0.9 L/kg) |
| Pharmacolibrary.Types.Clearance | k12 (from PK_2C) | 1 | intercompartmental C-P clearance |
| Pharmacolibrary.Types.Clearance | k21 (from PK_2C) | 1 | intercompartmental P-C clearance |
| Pharmacolibrary.Types.TransferRate | ka (from PK_2C_enteral) | 0.016666666666666666 | first order absorption rate |
| Modelica.Units.SI.Time | Tlag (from PK_2C_enteral) | 600 | delay between oral administration and absorption (default 10min) |
| Info › Therapeutic range (metadata, not used in equations) | |||
| Pharmacolibrary.Types.MassConcentration | Cmin (from PK_1C) | 0.004 | minimal therapeutic range |
| Pharmacolibrary.Types.MassConcentration | Cmax (from PK_1C) | 0.008 | maximal therapeutic range |
| Pharmacolibrary.Types.MassConcentration | Ctox_peak (from PK_1C) | 0.012 | toxicity peak level |
| Pharmacolibrary.Types.MassConcentration | Ctox_trough (from PK_1C) | 0.006 | toxicity trough level |
| Info › Substance metadata | |||
| Modelica.Units.SI.MolarMass | MM (from PK_1C) | 0 | molar mass [kg/mol]; 0 = not supplied (molar concentrations are then 0) |
| Info › Substance metadata (not used in equations) | |||
| Pharmacolibrary.Types.Dose | LD50 (from PK_1C) | 0 | median lethal dose [mg/kg]; 0 = unknown |
Connectors
| Type | Name | Default | Description |
|---|---|---|---|
| Types.ConcentrationOutput | C_central (from PK_1C) | ||
| Interfaces.ConcentrationPort_b | centralCPort (from PK_1C) | ||
| Interfaces.ConcentrationPort_b | peripheralCPort (from PK_2C) | ||
| Pharmacolibrary.Types.ConcentrationOutput | C_peripheral1 (from PK_2C) |
Components
| Type | Name | Default | Description |
|---|---|---|---|
| Pharmacokinetic.NoPerfusedTissueCompartment | central (from PK_1C) | ||
| Pharmacokinetic.ClearanceDrivenElimination | elim (from PK_1C) | ||
| Sources.PeriodicDose | periodicDose (from PK_1C) | ||
| Modelica.Units.SI.Time | t1_2 (from PK_1C) | central-compartment elimination half-life = ln(2)*Vd/Cl (1-compartment approximation; NOT the terminal half-life of 2-/3-compartment models) | |
| Pharmacolibrary.Pharmacokinetic.TransferFirstOrderNonSym | transfer (from PK_2C) | ||
| Pharmacolibrary.Pharmacokinetic.NoPerfusedTissueCompartment | peripheral (from PK_2C) |
Revisions
- 11/2026 generated by pharmacolibrary-dev export.pharmacolibrary_models from Langeskov_2022: parameters extracted from the paper by the pharmacolibrary-dev pipeline, model built by its engineer, reviewed: accepted with caveats